Ming-Wen An

S. Mandrekar, J. Le-Rademacher, Ming-Wen An, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Application of tumor measurement-based metrics in the real world.

D. Sargent, S. Mandrekar, Ming-Wen An, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

S. Mandrekar, F. Ou, Ming-Wen An, 2021, Contemporary clinical trials communications.

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials

D. Sargent, S. Mandrekar, A. Grothey, 2019, Contemporary clinical trials communications.

A Stochastic Simulator of a Blood Product Donation Environment with Demand Spikes and Supply Shocks

Thomas A. Louis, Nicholas G. Reich, Ron Brookmeyer, 2011, PloS one.

Principal Stratification Designs to Estimate Input Data Missing Due to Death

Ellen MacKenzie, Constantine E Frangakis, Donald B Rubin, 2007, Biometrics.

Subjective and Objective Sleep Quality and Aging in the Sleep Heart Health Study

J. L. Yeh, Daniel J Buysse, A. Newman, 2008, Journal of the American Geriatrics Society.

Longitudinal evaluation of sleep-disordered breathing and sleep symptoms with change in quality of life: the Sleep Heart Health Study (SHHS).

S. Redline, S. Quan, E. Shahar, 2009, Sleep.

A Cross-Over Study to Evaluate the Effect of Glucagon-Like Peptide 1 on Women with Polycystic Ovarian Syndrome

S. Tian, Ming-Wen An, Lu Wang, 2017 .

Evaluation of School-Based Smoking-Cessation Interventions for Self-Described Adolescent Smokers

D. Scharfstein, E. Colantuoni, C. McNeely, 2009, Pediatrics.

Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouse.

D. Sargent, S. Mandrekar, J. Bogaerts, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Precision oncology: A new era of cancer clinical trials.

Sumithra J Mandrekar, Lindsay A Renfro, Ming-Wen An, 2017, Cancer letters.

The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups

Xin Lu, Sumithra J. Mandrekar, Daniel J. Sargent, 2015, Comput. Math. Methods Medicine.

Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials

Sumithra J. Mandrekar, Henry C. Pitot, Daniel J. Sargent, 2011, Clinical Cancer Research.

Flexible random intercept models for binary outcomes using mixtures of normals

Brian Caffo, Charles Rohde, Ming-Wen An, 2007, Comput. Stat. Data Anal..

Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.

D. Sargent, S. Mandrekar, J. Bogaerts, 2015, Journal of the National Cancer Institute.

Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.

D. Sargent, S. Mandrekar, J. Bogaerts, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies.

S. Mandrekar, A. Ruppert, F. Ou, 2019, JCO precision oncology.

Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignment.

D. Sargent, S. Mandrekar, M. Edelman, 2014, Contemporary clinical trials.

Biomarkers-guided targeted drugs: New clinical trials design and practice necessity

D. Sargent, S. Mandrekar, Ming-Wen An, 2011 .

A 2-Stage Phase II Design with Direct Assignment Option in Stage II for Initial Marker Validation

D. Sargent, S. Mandrekar, Ming-Wen An, 2012, Clinical Cancer Research.

A review of phase II trial designs for initial marker validation.

D. Sargent, S. Mandrekar, Ming-Wen An, 2013, Contemporary clinical trials.